NCT05794100View on ClinicalTrials.gov

Evaluating the Impact of Different Sugar Replacer Combinations on Gastrointestinal Tolerance

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

October 11, 2021

Primary Completion Date

May 30, 2022

Study Completion Date

July 30, 2022

Conditions
ToleranceHealthy Population
Interventions
OTHER

Acute intake of one of the products (active comparator 1 to 9) or Placebo comparator

One pack of each product (1 to 10) will be consumed on a separate occasion

Trial Locations (1)

60101

Biofortis Innovation Services, Addison

Sponsors

Collaborators (1)

BioFortis
All Listed Sponsors
collaborator

BioFortis

OTHER

lead

Mondelēz International, Inc.

INDUSTRY